MABTHERA sous-cutané sol inj 1600 mg/13.4 ml flac
7680658130026
CH-65813
L01FA01
07.16.1.
1 / 3
google
Details
- Product number
- 6581302
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- rituximabum 1600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, methioninum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 13.4 ml.
Articles (1)
MabThera subkutan 1600 mg/13.4 ml, Lösung zur subkutanen Injektion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rituximabum
|
1600.0 MG | Substance | Wirkstoff (Principe actif) |
|
hyaluronidasum humanum ADNr
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 65813
- Drug name
- MabThera subkutan, Lösung zur subkutanen Injektion
- Galenic form
- LSPA
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/06/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MABTHERA sous-cutané sol inj 1600 mg/13.4 ml flac
- Description (DE)
- MABTHERA subkutan Inj Lös 1600 mg/13.4 ml Durchstf
- Market launch
- 08/05/2018
- Market withdrawal
- 01/07/2026
- Narcotic (BTM)
- No